Compare ADMA & NHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADMA | NHI |
|---|---|---|
| Founded | 2004 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.7B |
| IPO Year | N/A | 1991 |
| Metric | ADMA | NHI |
|---|---|---|
| Price | $19.49 | $76.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $28.50 | ★ $85.20 |
| AVG Volume (30 Days) | ★ 2.8M | 234.9K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 4.82% |
| EPS Growth | ★ 205.35 | 8.88 |
| EPS | 0.86 | ★ 3.17 |
| Revenue | ★ $488,559,000.00 | $357,572,000.00 |
| Revenue This Year | $22.19 | $5.50 |
| Revenue Next Year | $24.33 | $11.38 |
| P/E Ratio | ★ $23.22 | $24.12 |
| Revenue Growth | ★ 27.63 | 8.40 |
| 52 Week Low | $13.50 | $65.13 |
| 52 Week High | $25.67 | $80.56 |
| Indicator | ADMA | NHI |
|---|---|---|
| Relative Strength Index (RSI) | 59.08 | 44.37 |
| Support Level | $18.33 | $76.68 |
| Resistance Level | $19.94 | $79.09 |
| Average True Range (ATR) | 0.66 | 1.55 |
| MACD | -0.16 | -0.22 |
| Stochastic Oscillator | 56.86 | 15.49 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.